Relmada Therapeutics, Inc. RLMD Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s common stock, shares issued (in shares)?
- Relmada Therapeutics, Inc. (RLMD) reported common stock, shares issued (in shares) of $104.89M in Q1 2026.
- How has Relmada Therapeutics, Inc.'s common stock, shares issued (in shares) changed year-over-year?
- Relmada Therapeutics, Inc.'s common stock, shares issued (in shares) increased by 3376.2% year-over-year, from $3.02M to $104.89M.
- What is the long-term trend for Relmada Therapeutics, Inc.'s common stock, shares issued (in shares)?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s common stock, shares issued (in shares) has grown at a 35.0% compound annual growth rate (CAGR), from $16.33M to $73.33M.